Sanofi (SNY) News Today → Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad) Free SNY Stock Alerts $45.39 -0.72 (-1.56%) (As of 04/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSanofi to overhaul US operations of vaccines, cut jobsreuters.com - April 18 at 4:29 PMBrokers Issue Forecasts for Sanofi's Q1 2024 Earnings (NASDAQ:SNY)americanbankingnews.com - April 18 at 5:46 AMSanofi (SNY) Set to Announce Quarterly Earnings on Thursdayamericanbankingnews.com - April 18 at 1:08 AMNovartis Multiple Sclerosis Drug Kesimpta Shows Substantial Benefit Of Up To 6 Yearsbenzinga.com - April 17 at 12:56 PMCOTA Announces Strategic Collaboration with Sanofi to Leverage Real-World Data and AI to Accelerate Cancer Trialsbusinesswire.com - April 17 at 9:00 AMCookson Peirce & Co. Inc. Sells 484,123 Shares of Sanofi (NASDAQ:SNY)marketbeat.com - April 17 at 8:41 AMSanofi - Aventis Groupe: Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosisfinanznachrichten.de - April 17 at 3:05 AMSanofi (NASDAQ:SNY) Given Consensus Rating of "Hold" by Analystsamericanbankingnews.com - April 16 at 2:34 AMSanofi (NASDAQ:SNY) Shares Sold by Oak Family Advisors LLCmarketbeat.com - April 15 at 3:32 PMNovo Nordisk Arms Wegovy to Be a Triple Threat (SNY)marketbeat.com - April 15 at 7:30 AMMeitav Investment House Ltd. Decreases Holdings in Sanofi (NASDAQ:SNY)marketbeat.com - April 12 at 12:28 PMRegeneron hits three-month low after DOJ complaint; RBC defendsmsn.com - April 11 at 7:23 PMSanofi to shutter operations at Peninsula drug maker it bought less than 3 years agobizjournals.com - April 11 at 5:38 PMNurix gains after extending Sanofi research pactmsn.com - April 9 at 2:31 PMSanofi (NASDAQ:SNY) Sees Strong Trading Volumemarketbeat.com - April 9 at 12:54 PMMeet Europe's Mag 18. Novo Nordisk Stock, ASML, and Others Can Rival the Mag Seven.barrons.com - April 9 at 11:42 AMSanofi - AGM 30.04.2024 - Availability of Preparatory documentsglobenewswire.com - April 8 at 12:00 PMSanofi Layoffs 2024: What to Know About the Latest SNY Job Cutsinvestorplace.com - April 8 at 10:08 AMAugustine Asset Management Inc. Raises Stock Holdings in Sanofi (NASDAQ:SNY)marketbeat.com - April 6 at 8:15 AMSanofi shares target cut amid FDA Dupixent reviewinvesting.com - April 5 at 4:42 AMSanofi Announces Launch of Verorab® (Sanofi Inactivated Rabies Vaccine) in the UK for Pre-exposure and Post-exposure Prophylaxis of Rabies in All Age Groupsbusinesswire.com - April 5 at 4:15 AMChina Universal Asset Management Co. Ltd. Grows Stake in Sanofi (NASDAQ:SNY)marketbeat.com - April 4 at 6:54 PMDiabetes Drug Lixisenatide May Slow Down Parkinson's: Studyfinanznachrichten.de - April 4 at 4:38 PMSanofi to Resolve 4,000 Zantac Cancer Lawsuits in US Courtsmsn.com - April 4 at 1:42 PMIn Heart Burn Drug Zantac's Litigation Saga, Sanofi Nears Settlement in Major Lawsuit Clusterbenzinga.com - April 4 at 10:09 AMDiabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trialcnbc.com - April 4 at 9:56 AMDiabetes medication appears to slow progress of Parkinson’s disease in French-backed trialmsn.com - April 4 at 7:56 AMSanofi to Settle About 4,000 Suits Over Zantac Cancer Claimsmsn.com - April 3 at 7:28 PMSanofi to settle 4,000 Zantac cancer lawsuits in US state courtsreuters.com - April 3 at 5:33 PMSanofi: BUY as FDA reviews Dupixent for COPDfinance.yahoo.com - April 3 at 1:41 PMDAVENPORT & Co LLC Has $58.09 Million Holdings in Sanofi (NASDAQ:SNY)marketbeat.com - April 3 at 12:54 AMSNY Quantitative Stock Analysisnasdaq.com - April 1 at 8:43 PMXeris Biopharma: Checking-In On One Of My 'Top Ideas'seekingalpha.com - March 30 at 2:46 AMFirst Week of May 17th Options Trading For Sanofi (SNY)nasdaq.com - March 29 at 12:30 PMSanofi (NASDAQ:SNY) Announces Dividend Increase - $1.48 Per Sharemarketbeat.com - March 28 at 7:52 AMKrispy Kreme-McDonald's Deal Spikes Insulin Stock Interest: 'We're About To Cash In On The Aftermath'msn.com - March 26 at 7:58 PMPacer Advisors Inc. Raises Stock Holdings in Sanofi (NASDAQ:SNY)marketbeat.com - March 26 at 7:55 AMWall Street Lunch: Calhoun To Leave Boeingseekingalpha.com - March 25 at 10:34 PMPress Release: Availability of the Q1 2024 Memorandum for modelling purposesglobenewswire.com - March 22 at 2:30 AMDynamic Advisor Solutions LLC Takes $2.10 Million Position in Sanofi (NASDAQ:SNY)marketbeat.com - March 21 at 6:11 AMCGN Advisors LLC Sells 35,291 Shares of Sanofi (NASDAQ:SNY)marketbeat.com - March 16 at 7:02 AMSanofi: Information concerning the total number of voting rights and shares - February 2024finance.yahoo.com - March 15 at 3:18 PMPE Firms Eye €7.5 Billion Leveraged Financing for Sanofi Unitfinance.yahoo.com - March 15 at 12:51 PM12 Most Profitable Biotech Stocks To Invest Infinance.yahoo.com - March 14 at 10:12 AMPassport to Profits: 7 Global Growth Gems to Diversify Your Holdingsinvestorplace.com - March 13 at 2:52 PMSanofi (SNY) Barclays 26th Annual Global Healthcare Conference (Transcript)seekingalpha.com - March 13 at 10:25 AMSanofi (NASDAQ:SNY) Shares Purchased by Creative Planningmarketbeat.com - March 13 at 6:47 AMSanofi (SNY) Leerink Partners Global Biopharma Conference (Transcript)seekingalpha.com - March 12 at 2:29 PMMorgan Stanley Grows Holdings in Sanofi (NASDAQ:SNY)marketbeat.com - March 12 at 7:42 AMRegeneron's Praluent injection gets FDA approval to treat kids with genetic form of high cholesterolmsn.com - March 11 at 9:02 AM Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address You’re invited: Biggest crypto event of 2024 (Ad)During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024. Just click here to sign up and be among the first to get it. SNY Media Mentions By Week SNY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNY News Sentiment▼0.760.51▲Average Medical News Sentiment SNY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNY Articles This Week▼137▲SNY Articles Average Week Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BMY News VRTX News REGN News PFE News GSK News ZTS News ABT News TAK News NVS News BIIB News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNY) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlaceTop 5 AI Stocks to Buy for 2024Market Moving TrendsHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.